Cataract surgery is about to undergo a revolutionary advance—shifting from the conventional hand-held blade—to an ultramodern blade-free, femtosecond laser procedure which can treat even the hardest cataracts in mere minutes. Not since the “no-stitch” cataract procedure has the ophthalmology profession experienced such a seismic shift in eye surgery; and it’s now in Sarasota.
For nearly two years Center For Sight founder and CEO, David Shoemaker, M.D., has been cautiously monitoring developments related to the use of femtosecond lasers in cataract surgery with a keen interest in the technology offered through the LensAR Laser System designed by LensAR, Inc., an Orlando-based company. He was among a select group of 18 ophthalmologists from the U.S. and abroad who recently traveled to Lima, Peru to help deploy the technology in that country. While there, he performed laser cataract surgery on 20 patients with very dense cataracts and was amazed with the flawless execution of this amazing technology. He performed the first LensAR Laser Cataract procedure in the United States on August 1st.
“There is no doubt the LensAR Laser System will result in safer and more predictable outcomes for patients throughout the world,” says Dr. Shoemaker. “It is rare to experience a true ‘Wow!’ moment in medicine, and that is exactly what this laser does. We couldn’t be more excited to bring this technology to Sarasota.”
With Laser Cataract Surgery, the hand-held blade will be limited to a supporting role. The LensAR Laser System uses the most advanced scanning beam technology ever offered to surgeons. The system employs a proprietary, high resolution 3D-CSI measurement device combined with an advanced femtosecond laser designed to deliver laser pulse placement and surgical incisions with unsurpassed precision.
“LensAR Laser System has been successfully used outside the U.S. with excellent clinical success and reliability,” says Dr. Shoemaker. “It’s a privilege to be the first in country to offer the genius of this laser technology to our patients.”